Insulet Corp PODD

$131.69 +0.90 (0.69%)

Valuation

Market cap
9,070,808,000
Revenue TTM
$2,708,100,000
Net income TTM
$247,100,000
PE ratio
22.23
Forward PE
20.03
Profit margin
9.12%
Debt to equity
0.67

Trading

Volume
3,060,800
Avg volume
1,755,822
Day's range
$128.01 – $132.53
Shares out
69,354,000
Stochastic %K
26%
Beta
1.11
Analysts
Sell
Price target
$171.58

Price

Company profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values throu...

Show more

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
978 600 7000
Website
https://www.insulet.com
Address
100 Nagog Park, Acton, United States

Latest news

No headlines yet.

Stocktwits

razor4 Oct 1, 11:21 PM
$PODD Time to wakup....loding time??
0 replies
bulltrades1234 Sep 30, 2:02 PM
$PODD $352 bucks to $130 and going down 66 percent drawdown what next
0 replies
Wernerwager Sep 30, 12:43 AM
$PODD bleeding slowly, management just sitting back with their big paychecks and enjoying the show.
1 replies
MODDBlueInMyBlood Sep 29, 5:18 PM
$MMED $MODD $PODD $TNDM $BBNX ehich patent do you think they are infringing on?
1 replies
deepthinker Sep 29, 5:14 PM
$MMED If I’m this company, and I have ANY doubt about $MODD patent infringement, I am either buying Modular or signing a license deal with them. If there’s even a 20% chance, and $PODD, $TNDM or $BBNX buys Pivot, I could be royally screwed, as they stall out Fit in court or win big judgements.
0 replies
Merlintrader Sep 25, 10:31 PM
Diabetes: does the best device win the best business? $ABT, $DXCM, $PODD, $SENS https://www.merlintrader.com/diabetes-devices-business-abt-dxcm-podd-sens/
0 replies
deepthinker Sep 22, 3:00 PM
$MODD Anyone with a patch pump coming, especially $MMED, would probably be better off buying $MODD to short circuit any future patent challenges. If $PODD got ahold of Modular, that could be big trouble for Minimed.
1 replies
bulltrades1234 Sep 22, 2:08 PM
$PODD oh man this stock
0 replies